| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ephrin receptor activity | 1.34e-08 | 19 | 183 | 6 | GO:0005003 | |
| GeneOntologyMolecularFunction | transmembrane-ephrin receptor activity | 1.71e-07 | 15 | 183 | 5 | GO:0005005 | |
| GeneOntologyMolecularFunction | GPI-linked ephrin receptor activity | 2.34e-07 | 7 | 183 | 4 | GO:0005004 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.13e-06 | 85 | 183 | 8 | GO:0019199 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 2.15e-06 | 65 | 183 | 7 | GO:0004714 | |
| GeneOntologyMolecularFunction | HLA-A specific inhibitory MHC class I receptor activity | 7.47e-06 | 5 | 183 | 3 | GO:0030107 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 7.79e-06 | 145 | 183 | 9 | GO:0004713 | |
| GeneOntologyMolecularFunction | HLA-B specific inhibitory MHC class I receptor activity | 1.48e-05 | 6 | 183 | 3 | GO:0030109 | |
| GeneOntologyMolecularFunction | MHC class Ib protein complex binding | 2.58e-05 | 7 | 183 | 3 | GO:0023025 | |
| GeneOntologyMolecularFunction | L-ascorbic acid transmembrane transporter activity | 8.35e-05 | 2 | 183 | 2 | GO:0015229 | |
| GeneOntologyMolecularFunction | L-ascorbate:sodium symporter activity | 8.35e-05 | 2 | 183 | 2 | GO:0008520 | |
| GeneOntologyMolecularFunction | growth factor binding | 9.77e-05 | 156 | 183 | 8 | GO:0019838 | |
| GeneOntologyMolecularFunction | IgM binding | 1.18e-04 | 11 | 183 | 3 | GO:0001791 | |
| GeneOntologyMolecularFunction | inhibitory MHC class I receptor activity | 1.57e-04 | 12 | 183 | 3 | GO:0032396 | |
| GeneOntologyMolecularFunction | histone H3K9 acetyltransferase activity | 2.49e-04 | 3 | 183 | 2 | GO:0043992 | |
| GeneOntologyMolecularFunction | actin filament binding | 2.54e-04 | 227 | 183 | 9 | GO:0051015 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 3.55e-04 | 102 | 183 | 6 | GO:0001540 | |
| GeneOntologyMolecularFunction | MHC class Ib protein binding | 3.88e-04 | 16 | 183 | 3 | GO:0023029 | |
| GeneOntologyMolecularFunction | protein kinase activity | SPEG OBSCN TGFBR3 EPHA2 FES PRKCQ TAF1 FGFR4 TAF1L EPHA3 EPHA4 EPHA5 DYRK2 EPHA8 EPHB1 | 4.35e-04 | 600 | 183 | 15 | GO:0004672 |
| GeneOntologyMolecularFunction | carbohydrate:monoatomic cation symporter activity | 4.68e-04 | 17 | 183 | 3 | GO:0005402 | |
| GeneOntologyMolecularFunction | actin binding | MYO9A MYO9B ESPNL TRIOBP MEFV CORO2B SYNE3 MICALL2 PLEKHG3 FRG1 FSCN2 PPP1R18 CORO7 | 4.92e-04 | 479 | 183 | 13 | GO:0003779 |
| GeneOntologyMolecularFunction | MHC class I receptor activity | 5.58e-04 | 18 | 183 | 3 | GO:0032393 | |
| GeneOntologyMolecularFunction | MHC class Ib receptor activity | 6.59e-04 | 19 | 183 | 3 | GO:0032394 | |
| GeneOntologyMolecularFunction | phosphatase binding | 7.59e-04 | 264 | 183 | 9 | GO:0019902 | |
| GeneOntologyMolecularFunction | H3K27me3 modified histone binding | 8.20e-04 | 5 | 183 | 2 | GO:0061628 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | SPEG OBSCN DGKZ TGFBR3 EPHA2 FES PRKCQ TAF1 FGFR4 TAF1L EPHA3 EPHA4 EPHA5 DYRK2 EPHA8 EPHB1 | 8.48e-04 | 709 | 183 | 16 | GO:0016773 |
| GeneOntologyMolecularFunction | semaphorin receptor binding | 1.17e-03 | 23 | 183 | 3 | GO:0030215 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 1.22e-03 | 51 | 183 | 4 | GO:0004402 | |
| GeneOntologyMolecularFunction | SH2 domain binding | 1.31e-03 | 52 | 183 | 4 | GO:0042169 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 1.62e-03 | 55 | 183 | 4 | GO:0061733 | |
| GeneOntologyMolecularFunction | metalloaminopeptidase activity | 1.69e-03 | 26 | 183 | 3 | GO:0070006 | |
| GeneOntologyMolecularFunction | kinase activity | SPEG OBSCN DGKZ TGFBR3 EPHA2 FES PRKCQ TAF1 FGFR4 TAF1L EPHA3 EPHA4 EPHA5 DYRK2 EPHA8 EPHB1 | 1.83e-03 | 764 | 183 | 16 | GO:0016301 |
| GeneOntologyMolecularFunction | monosaccharide transmembrane transporter activity | 1.88e-03 | 27 | 183 | 3 | GO:0015145 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 2.23e-03 | 60 | 183 | 4 | GO:0034212 | |
| GeneOntologyMolecularFunction | structural constituent of presynaptic active zone | 2.26e-03 | 8 | 183 | 2 | GO:0098882 | |
| GeneOntologyMolecularFunction | NMDA glutamate receptor activity | 2.26e-03 | 8 | 183 | 2 | GO:0004972 | |
| GeneOntologyMolecularFunction | sugar transmembrane transporter activity | 2.32e-03 | 29 | 183 | 3 | GO:0051119 | |
| GeneOntologyMolecularFunction | chemorepellent activity | 2.32e-03 | 29 | 183 | 3 | GO:0045499 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | MYO9A MYO9B OBSCN DIS3 SYDE1 ARHGEF40 LLGL2 PLEKHG3 SBF2 TBC1D12 RIMS1 SEC23B | 2.56e-03 | 507 | 183 | 12 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | MYO9A MYO9B OBSCN DIS3 SYDE1 ARHGEF40 LLGL2 PLEKHG3 SBF2 TBC1D12 RIMS1 SEC23B | 2.56e-03 | 507 | 183 | 12 | GO:0030695 |
| GeneOntologyMolecularFunction | peptide binding | 2.73e-03 | 318 | 183 | 9 | GO:0042277 | |
| GeneOntologyMolecularFunction | RNA polymerase I general transcription initiation factor activity | 2.88e-03 | 9 | 183 | 2 | GO:0001181 | |
| GeneOntologyMolecularFunction | MHC class I protein binding | 3.09e-03 | 32 | 183 | 3 | GO:0042288 | |
| GeneOntologyMolecularFunction | metalloexopeptidase activity | 3.91e-03 | 70 | 183 | 4 | GO:0008235 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 3.99e-03 | 35 | 183 | 3 | GO:0005343 | |
| GeneOntologyMolecularFunction | protein phosphatase 1 binding | 3.99e-03 | 35 | 183 | 3 | GO:0008157 | |
| GeneOntologyMolecularFunction | immune receptor activity | 4.20e-03 | 165 | 183 | 6 | GO:0140375 | |
| GeneOntologyMolecularFunction | coreceptor activity | 4.32e-03 | 72 | 183 | 4 | GO:0015026 | |
| GeneOntologyMolecularFunction | immunoglobulin binding | 4.33e-03 | 36 | 183 | 3 | GO:0019865 | |
| GeneOntologyMolecularFunction | vitamin transmembrane transporter activity | 4.33e-03 | 36 | 183 | 3 | GO:0090482 | |
| GeneOntologyBiologicalProcess | axon guidance | CNTN4 APBB2 SEMA3G SEMA4C ARHGEF40 SEMA6D ROBO1 PRKCQ ROBO3 CNTN2 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 3.26e-08 | 285 | 180 | 15 | GO:0007411 |
| GeneOntologyBiologicalProcess | neuron projection guidance | CNTN4 APBB2 SEMA3G SEMA4C ARHGEF40 SEMA6D ROBO1 PRKCQ ROBO3 CNTN2 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 3.41e-08 | 286 | 180 | 15 | GO:0097485 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | CNTN4 SZT2 MYO9A MYO9B CNTNAP1 APBB2 GRIN1 SEMA3G EDN2 SEMA4C ARHGEF40 SEMA6D ROBO1 PRKCQ RIMS1 ROBO3 RIMS2 SLC23A2 CNTN2 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 2.07e-07 | 819 | 180 | 24 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | CNTN4 SZT2 MYO9A MYO9B CNTNAP1 APBB2 GRIN1 SEMA3G EDN2 SEMA4C ARHGEF40 SEMA6D ROBO1 PRKCQ RIMS1 ROBO3 RIMS2 SLC23A2 CNTN2 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 2.41e-07 | 826 | 180 | 24 | GO:0048858 |
| GeneOntologyBiologicalProcess | neuron development | CNTN4 IFT140 SZT2 MYO9A ZNF212 CNTNAP1 APBB2 TRIOBP NCAM2 GRIN1 SAMD7 SEMA3G EDN2 SEMA4C ARHGEF40 SEMA6D MICALL2 FES FSCN2 ROBO1 PRKCQ RIMS1 GRIN3A ROBO3 RIMS2 SLC23A2 SDK1 CNTN2 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 4.10e-07 | 1463 | 180 | 33 | GO:0048666 |
| GeneOntologyBiologicalProcess | ephrin receptor signaling pathway | 4.30e-07 | 54 | 180 | 7 | GO:0048013 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | CNTN4 SZT2 MYO9A CNTNAP1 APBB2 GRIN1 SEMA3G EDN2 SEMA4C ARHGEF40 SEMA6D ROBO1 PRKCQ RIMS1 ROBO3 RIMS2 SLC23A2 CNTN2 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 5.52e-07 | 802 | 180 | 23 | GO:0048812 |
| GeneOntologyBiologicalProcess | axonogenesis | CNTN4 SZT2 CNTNAP1 APBB2 GRIN1 SEMA3G EDN2 SEMA4C ARHGEF40 SEMA6D ROBO1 PRKCQ ROBO3 CNTN2 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 5.71e-07 | 566 | 180 | 19 | GO:0007409 |
| GeneOntologyBiologicalProcess | neuron projection development | CNTN4 SZT2 MYO9A ZNF212 CNTNAP1 APBB2 TRIOBP NCAM2 GRIN1 SEMA3G EDN2 SEMA4C ARHGEF40 SEMA6D MICALL2 FES ROBO1 PRKCQ RIMS1 GRIN3A ROBO3 RIMS2 SLC23A2 SDK1 CNTN2 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 7.40e-07 | 1285 | 180 | 30 | GO:0031175 |
| GeneOntologyBiologicalProcess | neuron recognition | 7.98e-07 | 59 | 180 | 7 | GO:0008038 | |
| GeneOntologyBiologicalProcess | axon development | CNTN4 SZT2 CNTNAP1 APBB2 NCAM2 GRIN1 SEMA3G EDN2 SEMA4C ARHGEF40 SEMA6D ROBO1 PRKCQ ROBO3 CNTN2 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 9.08e-07 | 642 | 180 | 20 | GO:0061564 |
| GeneOntologyBiologicalProcess | cell morphogenesis | CNTN4 SZT2 MYO9A MYO9B CNTNAP1 APBB2 TRIOBP GRIN1 SEMA3G EDN2 SEMA4C ARHGEF40 SYNE3 SEMA6D EPHA2 FES ROBO1 PRKCQ RIMS1 ROBO3 RIMS2 SLC23A2 CNTN2 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 1.67e-06 | 1194 | 180 | 28 | GO:0000902 |
| GeneOntologyBiologicalProcess | regulation of synaptic plasticity | CNTN4 LILRB2 GRIN1 KAT2A SNAP47 LILRB1 RIMS1 MMP9 RIMS2 NOS1 LILRB5 CNTN2 EPHA4 | 1.90e-06 | 293 | 180 | 13 | GO:0048167 |
| GeneOntologyBiologicalProcess | neuron projection fasciculation | 4.00e-06 | 28 | 180 | 5 | GO:0106030 | |
| GeneOntologyBiologicalProcess | axonal fasciculation | 4.00e-06 | 28 | 180 | 5 | GO:0007413 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | CNTN4 SZT2 CNTNAP1 APBB2 TRIOBP GRIN1 SEMA3G EDN2 SEMA4C ARHGEF40 SEMA6D ROBO1 PRKCQ ROBO3 CNTN2 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 9.05e-06 | 748 | 180 | 20 | GO:0048667 |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | CNTN4 LILRB2 GRIN1 KAT2A SNAP47 LILRB1 SYDE1 SLC6A1 RIMS1 GRIN3A MMP9 RIMS2 NOS1 LILRB5 TENT2 CNTN2 EPHA4 EPHB1 | 2.13e-05 | 663 | 180 | 18 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | CNTN4 LILRB2 GRIN1 KAT2A SNAP47 LILRB1 SYDE1 SLC6A1 RIMS1 GRIN3A MMP9 RIMS2 NOS1 LILRB5 TENT2 CNTN2 EPHA4 EPHB1 | 2.17e-05 | 664 | 180 | 18 | GO:0099177 |
| GeneOntologyBiologicalProcess | response to follicle-stimulating hormone | 2.99e-05 | 21 | 180 | 4 | GO:0032354 | |
| GeneOntologyBiologicalProcess | synapse organization | CNTN4 SDK2 MYO9A LILRB2 CNTNAP1 APBB2 DGKZ GRIN1 SEMA4C SLC6A1 ROBO1 RIMS2 SDK1 CNTN2 EPHA3 EPHA4 EPHA5 EPHB1 | 3.27e-05 | 685 | 180 | 18 | GO:0050808 |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission | LILRB2 GRIN1 SNAP47 LILRB1 SYDE1 RIMS1 RIMS2 NOS1 LILRB5 EPHA4 | 3.99e-05 | 233 | 180 | 10 | GO:0050806 |
| GeneOntologyBiologicalProcess | cell junction organization | CNTN4 SDK2 MYO9A LILRB2 CNTNAP1 APBB2 DGKZ GRIN1 SEMA4C SLC6A1 CORO2B MICALL2 EPHA2 ROBO1 MMP14 RIMS2 SDK1 CNTN2 EPHA3 EPHA4 EPHA5 EPHB1 | 4.27e-05 | 974 | 180 | 22 | GO:0034330 |
| GeneOntologyBiologicalProcess | fasciculation of motor neuron axon | 7.57e-05 | 2 | 180 | 2 | GO:0097156 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA endoreduplication | 7.57e-05 | 2 | 180 | 2 | GO:0032877 | |
| GeneOntologyBiologicalProcess | synaptic vesicle fusion to presynaptic active zone membrane | 1.47e-04 | 31 | 180 | 4 | GO:0031629 | |
| GeneOntologyBiologicalProcess | response to gonadotropin | 1.67e-04 | 32 | 180 | 4 | GO:0034698 | |
| GeneOntologyBiologicalProcess | vesicle fusion to plasma membrane | 1.67e-04 | 32 | 180 | 4 | GO:0099500 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle fusion to presynaptic active zone membrane | 1.75e-04 | 13 | 180 | 3 | GO:0031632 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle membrane organization | 1.75e-04 | 13 | 180 | 3 | GO:1901634 | |
| GeneOntologyBiologicalProcess | calcium-dependent activation of synaptic vesicle fusion | 1.75e-04 | 13 | 180 | 3 | GO:0099502 | |
| GeneOntologyBiologicalProcess | positive regulation of long-term synaptic depression | 2.22e-04 | 14 | 180 | 3 | GO:1900454 | |
| GeneOntologyBiologicalProcess | fasciculation of sensory neuron axon | 2.26e-04 | 3 | 180 | 2 | GO:0097155 | |
| GeneOntologyBiologicalProcess | protein K6-linked deubiquitination | 2.26e-04 | 3 | 180 | 2 | GO:0044313 | |
| GeneOntologyBiologicalProcess | L-ascorbic acid transmembrane transport | 2.26e-04 | 3 | 180 | 2 | GO:0015882 | |
| GeneOntologyBiologicalProcess | synaptic vesicle membrane organization | 2.66e-04 | 36 | 180 | 4 | GO:0048499 | |
| GeneOntologyBiologicalProcess | cellular response to follicle-stimulating hormone stimulus | 2.75e-04 | 15 | 180 | 3 | GO:0071372 | |
| GeneOntologyBiologicalProcess | long-term synaptic potentiation | 2.76e-04 | 144 | 180 | 7 | GO:0060291 | |
| GeneOntologyBiologicalProcess | regulation of long-term synaptic potentiation | 2.98e-04 | 67 | 180 | 5 | GO:1900271 | |
| GeneOntologyBiologicalProcess | cell recognition | 3.58e-04 | 198 | 180 | 8 | GO:0008037 | |
| GeneOntologyBiologicalProcess | actin filament-based process | LURAP1 MYO9B ESPNL OBSCN TRIOBP SYDE1 SLC4A2 CORO2B LLGL2 HMCN1 KASH5 MICALL2 FSCN2 CACNA1H PRKCQ CORO7 NOS1 EPHA3 EPHA5 | 4.05e-04 | 912 | 180 | 19 | GO:0030029 |
| GeneOntologyBiologicalProcess | synaptic vesicle docking | 4.06e-04 | 17 | 180 | 3 | GO:0016081 | |
| GeneOntologyBiologicalProcess | regulation of DNA endoreduplication | 4.49e-04 | 4 | 180 | 2 | GO:0032875 | |
| GeneOntologyBiologicalProcess | dendrite self-avoidance | 4.84e-04 | 18 | 180 | 3 | GO:0070593 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | CNTN4 LILRB2 SYT9 GRIN1 KAT2A SNAP47 LILRB1 SYDE1 SLC6A1 RIMS1 GRIN3A MMP9 RIMS2 NOS1 LILRB5 TENT2 CNTN2 EPHA4 EPHB1 | 5.21e-04 | 931 | 180 | 19 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | CNTN4 LILRB2 SYT9 GRIN1 KAT2A SNAP47 LILRB1 SYDE1 SLC6A1 RIMS1 GRIN3A MMP9 RIMS2 NOS1 LILRB5 TENT2 CNTN2 EPHA4 EPHB1 | 5.21e-04 | 931 | 180 | 19 | GO:0007268 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | CNTN4 LILRB2 SYT9 GRIN1 KAT2A SNAP47 LILRB1 SYDE1 SLC6A1 RIMS1 GRIN3A MMP9 RIMS2 NOS1 LILRB5 TENT2 CNTN2 EPHA4 EPHB1 | 5.77e-04 | 939 | 180 | 19 | GO:0099537 |
| GeneOntologyBiologicalProcess | chemotaxis | MYO9B SEMA3G EDN2 SEMA4C SEMA6D CSF3R EPHA2 FES ROBO1 PRKCQ ROBO3 MMP9 EPHB1 | 6.35e-04 | 517 | 180 | 13 | GO:0006935 |
| GeneOntologyBiologicalProcess | taxis | MYO9B SEMA3G EDN2 SEMA4C SEMA6D CSF3R EPHA2 FES ROBO1 PRKCQ ROBO3 MMP9 EPHB1 | 6.58e-04 | 519 | 180 | 13 | GO:0042330 |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle fusion to presynaptic active zone membrane | 6.68e-04 | 20 | 180 | 3 | GO:0031630 | |
| GeneOntologyBiologicalProcess | positive regulation of vesicle fusion | 6.68e-04 | 20 | 180 | 3 | GO:0031340 | |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle membrane organization | 6.68e-04 | 20 | 180 | 3 | GO:1901632 | |
| GeneOntologyBiologicalProcess | DNA endoreduplication | 7.44e-04 | 5 | 180 | 2 | GO:0042023 | |
| GeneOntologyBiologicalProcess | protein localization to juxtaparanode region of axon | 7.44e-04 | 5 | 180 | 2 | GO:0071205 | |
| GeneOntologyBiologicalProcess | Fc receptor mediated inhibitory signaling pathway | 7.44e-04 | 5 | 180 | 2 | GO:0002774 | |
| GeneOntologyCellularComponent | Fc-epsilon receptor I complex | 5.25e-05 | 9 | 182 | 3 | GO:0032998 | |
| GeneOntologyCellularComponent | Fc receptor complex | 1.35e-04 | 12 | 182 | 3 | GO:0032997 | |
| Domain | FN3 | IL11RA CNTN4 SDK2 SPEG OBSCN IGDCC3 NCAM2 FNDC3A LEPR CSF3R EPHA2 ROBO1 ROBO3 SDK1 CNTN2 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 7.46e-16 | 185 | 175 | 20 | SM00060 |
| Domain | fn3 | IL11RA CNTN4 SDK2 SPEG OBSCN IGDCC3 NCAM2 FNDC3A CSF3R EPHA2 ROBO1 ROBO3 SDK1 CNTN2 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 8.89e-16 | 162 | 175 | 19 | PF00041 |
| Domain | FN3 | IL11RA CNTN4 SDK2 SPEG OBSCN IGDCC3 NCAM2 FNDC3A LEPR CSF3R EPHA2 ROBO1 ROBO3 SDK1 CNTN2 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 3.10e-15 | 199 | 175 | 20 | PS50853 |
| Domain | FN3_dom | IL11RA CNTN4 SDK2 SPEG OBSCN IGDCC3 NCAM2 FNDC3A LEPR CSF3R EPHA2 ROBO1 ROBO3 SDK1 CNTN2 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 8.02e-15 | 209 | 175 | 20 | IPR003961 |
| Domain | Ig-like_fold | IL11RA CNTN4 SDK2 LILRB2 SPEG OBSCN IGDCC3 NCAM2 FNDC3A SEMA3G NCR3LG1 LILRB1 LEPR SLC4A2 SEMA4C HMCN1 CSF3R EPHA2 CD300LB ROBO1 FGFR4 ROBO3 SDK1 LILRB5 CNTN2 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 3.43e-12 | 706 | 175 | 30 | IPR013783 |
| Domain | - | IL11RA CNTN4 SDK2 SPEG OBSCN IGDCC3 NCAM2 FNDC3A SEMA3G NCR3LG1 LILRB1 LEPR SEMA4C HMCN1 CSF3R EPHA2 CD300LB ROBO1 FGFR4 ROBO3 SDK1 LILRB5 CNTN2 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 2.28e-11 | 663 | 175 | 28 | 2.60.40.10 |
| Domain | RECEPTOR_TYR_KIN_V_2 | 1.75e-09 | 14 | 175 | 6 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 1.75e-09 | 14 | 175 | 6 | PS00790 | |
| Domain | Tyr_kinase_rcpt_V_CS | 1.75e-09 | 14 | 175 | 6 | IPR001426 | |
| Domain | EphA2_TM | 1.75e-09 | 14 | 175 | 6 | PF14575 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 1.75e-09 | 14 | 175 | 6 | IPR001090 | |
| Domain | Eph_TM | 1.75e-09 | 14 | 175 | 6 | IPR027936 | |
| Domain | EPH_lbd | 1.75e-09 | 14 | 175 | 6 | SM00615 | |
| Domain | Ephrin_lbd | 1.75e-09 | 14 | 175 | 6 | PF01404 | |
| Domain | Tyr_kinase_ephrin_rcpt | 1.75e-09 | 14 | 175 | 6 | IPR016257 | |
| Domain | EPH_LBD | 1.75e-09 | 14 | 175 | 6 | PS51550 | |
| Domain | Ig-like_dom | IL11RA CNTN4 SDK2 LILRB2 SPEG OBSCN IGDCC3 NCAM2 SEMA3G NCR3LG1 LILRB1 LEPR SEMA4C HMCN1 CSF3R CD300LB ROBO1 FGFR4 ROBO3 SDK1 LILRB5 CNTN2 | 2.03e-09 | 503 | 175 | 22 | IPR007110 |
| Domain | IG | IL11RA CNTN4 SDK2 LILRB2 SPEG OBSCN IGDCC3 NCAM2 SEMA3G NCR3LG1 LILRB1 SEMA4C HMCN1 CD300LB ROBO1 FGFR4 ROBO3 SDK1 LILRB5 CNTN2 | 2.87e-09 | 421 | 175 | 20 | SM00409 |
| Domain | Ig_sub | IL11RA CNTN4 SDK2 LILRB2 SPEG OBSCN IGDCC3 NCAM2 SEMA3G NCR3LG1 LILRB1 SEMA4C HMCN1 CD300LB ROBO1 FGFR4 ROBO3 SDK1 LILRB5 CNTN2 | 2.87e-09 | 421 | 175 | 20 | IPR003599 |
| Domain | IG_LIKE | IL11RA CNTN4 SDK2 LILRB2 SPEG OBSCN IGDCC3 NCAM2 SEMA3G NCR3LG1 LILRB1 LEPR SEMA4C HMCN1 CD300LB ROBO1 FGFR4 ROBO3 SDK1 LILRB5 CNTN2 | 7.20e-09 | 491 | 175 | 21 | PS50835 |
| Domain | IGc2 | CNTN4 SDK2 SPEG OBSCN IGDCC3 NCAM2 LILRB1 HMCN1 ROBO1 FGFR4 ROBO3 SDK1 LILRB5 CNTN2 | 4.79e-08 | 235 | 175 | 14 | SM00408 |
| Domain | Ig_sub2 | CNTN4 SDK2 SPEG OBSCN IGDCC3 NCAM2 LILRB1 HMCN1 ROBO1 FGFR4 ROBO3 SDK1 LILRB5 CNTN2 | 4.79e-08 | 235 | 175 | 14 | IPR003598 |
| Domain | Ephrin_rec_like | 9.49e-08 | 25 | 175 | 6 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 9.49e-08 | 25 | 175 | 6 | IPR011641 | |
| Domain | Ig_I-set | CNTN4 SDK2 SPEG OBSCN IGDCC3 NCAM2 HMCN1 ROBO1 FGFR4 ROBO3 SDK1 CNTN2 | 2.40e-07 | 190 | 175 | 12 | IPR013098 |
| Domain | I-set | CNTN4 SDK2 SPEG OBSCN IGDCC3 NCAM2 HMCN1 ROBO1 FGFR4 ROBO3 SDK1 CNTN2 | 2.40e-07 | 190 | 175 | 12 | PF07679 |
| Domain | ig | IL11RA CNTN4 SDK2 OBSCN IGDCC3 NCAM2 SEMA3G LILRB1 HMCN1 FGFR4 LILRB5 CNTN2 | 2.40e-07 | 190 | 175 | 12 | PF00047 |
| Domain | Immunoglobulin | IL11RA CNTN4 SDK2 OBSCN IGDCC3 NCAM2 SEMA3G LILRB1 HMCN1 FGFR4 LILRB5 CNTN2 | 2.40e-07 | 190 | 175 | 12 | IPR013151 |
| Domain | PROTEIN_KINASE_TYR | 3.19e-07 | 97 | 175 | 9 | PS00109 | |
| Domain | Tyr_kinase_AS | 3.19e-07 | 97 | 175 | 9 | IPR008266 | |
| Domain | Tyr_kinase_cat_dom | 1.72e-06 | 88 | 175 | 8 | IPR020635 | |
| Domain | TyrKc | 1.72e-06 | 88 | 175 | 8 | SM00219 | |
| Domain | - | 5.44e-06 | 73 | 175 | 7 | 2.60.120.260 | |
| Domain | DUF3669_Znf | 1.58e-05 | 6 | 175 | 3 | IPR022137 | |
| Domain | DUF3669 | 1.58e-05 | 6 | 175 | 3 | PF12417 | |
| Domain | SAM | 1.89e-05 | 88 | 175 | 7 | SM00454 | |
| Domain | Galactose-bd-like | 2.90e-05 | 94 | 175 | 7 | IPR008979 | |
| Domain | Pkinase_Tyr | 2.94e-05 | 129 | 175 | 8 | PF07714 | |
| Domain | SAM_DOMAIN | 3.11e-05 | 95 | 175 | 7 | PS50105 | |
| Domain | SAM | 3.55e-05 | 97 | 175 | 7 | IPR001660 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 4.77e-05 | 138 | 175 | 8 | IPR001245 | |
| Domain | - | 6.28e-05 | 106 | 175 | 7 | 1.10.150.50 | |
| Domain | TFIID_sub1_DUF3591 | 8.73e-05 | 2 | 175 | 2 | IPR022591 | |
| Domain | TBP-binding | 8.73e-05 | 2 | 175 | 2 | PF09247 | |
| Domain | DUF3591 | 8.73e-05 | 2 | 175 | 2 | PF12157 | |
| Domain | TAF_II_230-bd | 8.73e-05 | 2 | 175 | 2 | IPR009067 | |
| Domain | - | 8.73e-05 | 2 | 175 | 2 | 1.10.1100.10 | |
| Domain | TAF1_animal | 8.73e-05 | 2 | 175 | 2 | IPR011177 | |
| Domain | SAM/pointed | 1.17e-04 | 117 | 175 | 7 | IPR013761 | |
| Domain | Protein_kinase_ATP_BS | SPEG OBSCN EPHA2 FES PRKCQ FGFR4 EPHA3 EPHA4 EPHA5 DYRK2 EPHA8 EPHB1 | 2.47e-04 | 379 | 175 | 12 | IPR017441 |
| Domain | Xan_ur_permease | 2.60e-04 | 3 | 175 | 2 | PF00860 | |
| Domain | Xant/urac/vitC | 2.60e-04 | 3 | 175 | 2 | IPR006043 | |
| Domain | SSDP_DNA-bd | 2.60e-04 | 3 | 175 | 2 | IPR008116 | |
| Domain | SAM_1 | 4.41e-04 | 68 | 175 | 5 | PF00536 | |
| Domain | Neural_cell_adh | 5.17e-04 | 4 | 175 | 2 | IPR009138 | |
| Domain | Actin_cross-linking | 5.17e-04 | 4 | 175 | 2 | IPR008999 | |
| Domain | Lep_receptor_Ig | 5.17e-04 | 4 | 175 | 2 | PF06328 | |
| Domain | IgC2-like_lig-bd | 5.17e-04 | 4 | 175 | 2 | IPR010457 | |
| Domain | Semaphorin | 8.20e-04 | 20 | 175 | 3 | IPR027231 | |
| Domain | PROTEIN_KINASE_ATP | SPEG OBSCN EPHA2 FES PRKCQ FGFR4 EPHA3 EPHA4 EPHA5 DYRK2 EPHA8 EPHB1 | 1.33e-03 | 459 | 175 | 12 | PS00107 |
| Domain | Trimer_CC | 1.78e-03 | 7 | 175 | 2 | IPR015049 | |
| Domain | DUF1899 | 1.78e-03 | 7 | 175 | 2 | IPR015048 | |
| Domain | Trimer_CC | 1.78e-03 | 7 | 175 | 2 | PF08954 | |
| Domain | DUF1899 | 1.78e-03 | 7 | 175 | 2 | PF08953 | |
| Domain | Coronin | 1.78e-03 | 7 | 175 | 2 | IPR015505 | |
| Domain | Hematopoietin_rcpt_Gp130_CS | 1.78e-03 | 7 | 175 | 2 | IPR003529 | |
| Domain | DUF1899 | 1.78e-03 | 7 | 175 | 2 | SM01166 | |
| Domain | Bromodomain_CS | 1.79e-03 | 26 | 175 | 3 | IPR018359 | |
| Domain | THIOL_PROTEASE_CYS | 1.79e-03 | 26 | 175 | 3 | PS00139 | |
| Domain | THIOL_PROTEASE_ASN | 2.00e-03 | 27 | 175 | 3 | PS00640 | |
| Domain | THIOL_PROTEASE_HIS | 2.00e-03 | 27 | 175 | 3 | PS00639 | |
| Domain | C2 | 2.22e-03 | 142 | 175 | 6 | PS50004 | |
| Domain | LisH | 2.23e-03 | 28 | 175 | 3 | IPR006594 | |
| Domain | Pept_cys_AS | 2.23e-03 | 28 | 175 | 3 | IPR000169 | |
| Domain | LisH | 2.23e-03 | 28 | 175 | 3 | SM00667 | |
| Domain | LISH | 2.23e-03 | 28 | 175 | 3 | PS50896 | |
| Domain | Prot_kinase_dom | SPEG OBSCN EPHA2 FES PRKCQ FGFR4 EPHA3 EPHA4 EPHA5 DYRK2 EPHA8 EPHB1 | 2.26e-03 | 489 | 175 | 12 | IPR000719 |
| Domain | ZINC_PROTEASE | 2.30e-03 | 98 | 175 | 5 | PS00142 | |
| Domain | HEMATOPO_REC_L_F2 | 2.36e-03 | 8 | 175 | 2 | PS01353 | |
| Domain | E2F | 2.36e-03 | 8 | 175 | 2 | IPR015633 | |
| Domain | PROTEIN_KINASE_DOM | SPEG OBSCN EPHA2 FES PRKCQ FGFR4 EPHA3 EPHA4 EPHA5 DYRK2 EPHA8 EPHB1 | 2.42e-03 | 493 | 175 | 12 | PS50011 |
| Domain | Znf_FYVE_PHD | 2.64e-03 | 147 | 175 | 6 | IPR011011 | |
| Domain | - | 2.73e-03 | 148 | 175 | 6 | 2.60.40.150 | |
| Domain | Semap_dom | 3.00e-03 | 31 | 175 | 3 | IPR001627 | |
| Domain | SEMA | 3.00e-03 | 31 | 175 | 3 | PS51004 | |
| Domain | Sema | 3.00e-03 | 31 | 175 | 3 | SM00630 | |
| Domain | Sema | 3.00e-03 | 31 | 175 | 3 | PF01403 | |
| Domain | ZF_DAG_PE_1 | 3.06e-03 | 64 | 175 | 4 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 3.06e-03 | 64 | 175 | 4 | PS50081 | |
| Domain | C1 | 3.23e-03 | 65 | 175 | 4 | SM00109 | |
| Domain | Plexin_repeat | 3.28e-03 | 32 | 175 | 3 | IPR002165 | |
| Domain | PSI | 3.28e-03 | 32 | 175 | 3 | PF01437 | |
| Domain | PE/DAG-bd | 3.42e-03 | 66 | 175 | 4 | IPR002219 | |
| Domain | Growth_fac_rcpt_ | 3.55e-03 | 156 | 175 | 6 | IPR009030 | |
| Domain | Znf_FYVE-rel | 3.91e-03 | 34 | 175 | 3 | IPR017455 | |
| Domain | C2_dom | 4.53e-03 | 164 | 175 | 6 | IPR000008 | |
| Domain | FYVE_2 | 4.54e-03 | 11 | 175 | 2 | PF02318 | |
| Domain | E2F_TDP | 4.54e-03 | 11 | 175 | 2 | PF02319 | |
| Domain | PNMA | 4.54e-03 | 11 | 175 | 2 | IPR026523 | |
| Domain | PNMA | 4.54e-03 | 11 | 175 | 2 | PF14893 | |
| Pathway | KEGG_AXON_GUIDANCE | SEMA3G SEMA4C SEMA6D EPHA2 FES ROBO1 ROBO3 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 2.83e-09 | 129 | 132 | 12 | M5539 |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 4.42e-07 | 51 | 132 | 7 | M27311 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 2.30e-06 | 92 | 132 | 8 | M27201 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 6.61e-06 | 29 | 132 | 5 | M27309 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 1.49e-05 | 34 | 132 | 5 | MM15025 | |
| Pathway | PID_EPHA_FWDPATHWAY | 1.49e-05 | 34 | 132 | 5 | M177 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | MYO9B CNTNAP1 GRIN1 SEMA6D EPHA2 FES ROBO1 CACNA1H PRKCQ ROBO3 MMP9 CNTN2 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 2.59e-05 | 575 | 132 | 17 | M29853 |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 3.16e-05 | 65 | 132 | 6 | MM14911 | |
| Pathway | WP_SPINAL_CORD_INJURY | 6.84e-05 | 108 | 132 | 7 | MM15954 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 1.72e-04 | 261 | 132 | 10 | MM15676 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ENGASE MGAT4B ZNF585A ZNF48 SZT2 MYO9B SPEG TMEM158 RNPEPL1 KAT6A OBSCN ANKLE1 KAT2A LARS2 ADCY9 C6orf132 ARHGEF40 LLGL2 SYNE3 CD2BP2 SBF2 HPS6 CACNA1H ZNF324B SSBP4 MMP14 FOXK1 | 6.51e-11 | 1105 | 188 | 27 | 35748872 |
| Pubmed | 6.67e-11 | 14 | 188 | 6 | 26941654 | ||
| Pubmed | Disruption of segmental neural crest migration and ephrin expression in delta-1 null mice. | 2.71e-10 | 17 | 188 | 6 | 12217323 | |
| Pubmed | 5.42e-10 | 9 | 188 | 5 | 11403717 | ||
| Pubmed | Expression of Ephs and ephrins in developing mouse inner ear. | 5.89e-10 | 19 | 188 | 6 | 12684176 | |
| Pubmed | Multiple roles of EPH receptors and ephrins in neural development. | 8.38e-10 | 20 | 188 | 6 | 11256076 | |
| Pubmed | 8.38e-10 | 20 | 188 | 6 | 10207129 | ||
| Pubmed | 8.38e-10 | 20 | 188 | 6 | 9530499 | ||
| Pubmed | 8.38e-10 | 20 | 188 | 6 | 9576626 | ||
| Pubmed | 1.08e-09 | 10 | 188 | 5 | 25073978 | ||
| Pubmed | EphA receptors inhibit anti-CD3-induced apoptosis in thymocytes. | 1.08e-09 | 10 | 188 | 5 | 16547242 | |
| Pubmed | 1.17e-09 | 21 | 188 | 6 | 9267020 | ||
| Pubmed | 1.17e-09 | 21 | 188 | 6 | 11128993 | ||
| Pubmed | Eph receptors and ephrins demarcate cerebellar lobules before and during their formation. | 1.17e-09 | 21 | 188 | 6 | 10495276 | |
| Pubmed | Developmental expression of Eph and ephrin family genes in mammalian small intestine. | 1.17e-09 | 21 | 188 | 6 | 20112066 | |
| Pubmed | Eph receptors and ephrins: regulators of guidance and assembly. | 1.17e-09 | 21 | 188 | 6 | 10730216 | |
| Pubmed | 1.97e-09 | 11 | 188 | 5 | 15517401 | ||
| Pubmed | Eph receptors and their ephrin ligands are expressed in developing mouse pancreas. | 2.86e-09 | 24 | 188 | 6 | 16446123 | |
| Pubmed | EphrinA-EphA receptor interactions in mouse spinal neurulation: implications for neural fold fusion. | 3.36e-09 | 12 | 188 | 5 | 19247962 | |
| Pubmed | Eph-ephrin A system regulates murine blastocyst attachment and spreading. | 5.44e-09 | 13 | 188 | 5 | 17039519 | |
| Pubmed | 5.44e-09 | 13 | 188 | 5 | 12528186 | ||
| Pubmed | 1.31e-08 | 52 | 188 | 7 | 26633812 | ||
| Pubmed | 1.75e-08 | 83 | 188 | 8 | 11114734 | ||
| Pubmed | 7.59e-08 | 40 | 188 | 6 | 30898150 | ||
| Pubmed | Zic2-dependent axon midline avoidance controls the formation of major ipsilateral tracts in the CNS. | 1.36e-07 | 23 | 188 | 5 | 24360543 | |
| Pubmed | Promotion of proliferation in the developing cerebral cortex by EphA4 forward signaling. | 1.36e-07 | 23 | 188 | 5 | 19542359 | |
| Pubmed | Thalamic afferents influence cortical progenitors via ephrin A5-EphA4 interactions. | 1.36e-07 | 23 | 188 | 5 | 25480914 | |
| Pubmed | 1.55e-07 | 3 | 188 | 3 | 7609620 | ||
| Pubmed | 1.69e-07 | 10 | 188 | 4 | 28197551 | ||
| Pubmed | 2.59e-07 | 117 | 188 | 8 | 17145500 | ||
| Pubmed | 2.65e-07 | 11 | 188 | 4 | 22171039 | ||
| Pubmed | 2.65e-07 | 11 | 188 | 4 | 10559410 | ||
| Pubmed | 3.96e-07 | 12 | 188 | 4 | 1281307 | ||
| Pubmed | Ephrin/ephrin receptor expression during early stages of mouse inner ear development. | 3.96e-07 | 12 | 188 | 4 | 21465626 | |
| Pubmed | LERK-7: a ligand of the Eph-related kinases is developmentally regulated in the brain. | 6.19e-07 | 4 | 188 | 3 | 9245480 | |
| Pubmed | 6.19e-07 | 4 | 188 | 3 | 18986510 | ||
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 6.65e-07 | 91 | 188 | 7 | 28558017 | |
| Pubmed | A role for the EphA family in the topographic targeting of vomeronasal axons. | 7.93e-07 | 14 | 188 | 4 | 11222144 | |
| Pubmed | 1.08e-06 | 15 | 188 | 4 | 36028553 | ||
| Pubmed | 1.43e-06 | 16 | 188 | 4 | 8755474 | ||
| Pubmed | Regulation of cytotoxic T lymphocyte triggering by PIR-B on dendritic cells. | 1.54e-06 | 5 | 188 | 3 | 18787130 | |
| Pubmed | 1.54e-06 | 5 | 188 | 3 | 15084255 | ||
| Pubmed | 1.54e-06 | 5 | 188 | 3 | 27443384 | ||
| Pubmed | The inhibitory receptor PIR-B negatively regulates neutrophil and macrophage integrin signaling. | 1.54e-06 | 5 | 188 | 3 | 15494528 | |
| Pubmed | 1.54e-06 | 5 | 188 | 3 | 37146940 | ||
| Pubmed | PirB regulates a structural substrate for cortical plasticity. | 1.54e-06 | 5 | 188 | 3 | 24302763 | |
| Pubmed | 1.54e-06 | 5 | 188 | 3 | 23927735 | ||
| Pubmed | 1.54e-06 | 5 | 188 | 3 | 21087927 | ||
| Pubmed | 1.54e-06 | 5 | 188 | 3 | 20398663 | ||
| Pubmed | Regulation of plasmacytoid dendritic cell responses by PIR-B. | 1.54e-06 | 5 | 188 | 3 | 22948046 | |
| Pubmed | 1.54e-06 | 5 | 188 | 3 | 9054430 | ||
| Pubmed | 1.54e-06 | 5 | 188 | 3 | 19949912 | ||
| Pubmed | The ephrin signaling pathway regulates morphology and adhesion of mouse granulosa cells in vitro. | 1.54e-06 | 5 | 188 | 3 | 23242526 | |
| Pubmed | 1.54e-06 | 5 | 188 | 3 | 27324131 | ||
| Pubmed | Paired immunoglobulin-like receptor B regulates platelet activation. | 1.54e-06 | 5 | 188 | 3 | 25075127 | |
| Pubmed | Paired immunoglobulin-like receptors and their MHC class I recognition. | 1.54e-06 | 5 | 188 | 3 | 16011512 | |
| Pubmed | Mast cell regulation via paired immunoglobulin-like receptor PIR-B. | 1.54e-06 | 5 | 188 | 3 | 12403357 | |
| Pubmed | 1.54e-06 | 5 | 188 | 3 | 34242819 | ||
| Pubmed | 1.54e-06 | 5 | 188 | 3 | 20976309 | ||
| Pubmed | 1.54e-06 | 5 | 188 | 3 | 20881122 | ||
| Pubmed | 1.54e-06 | 5 | 188 | 3 | 19684158 | ||
| Pubmed | PirB functions as an intrinsic suppressor in hippocampal neural stem cells. | 1.54e-06 | 5 | 188 | 3 | 34120891 | |
| Pubmed | 1.54e-06 | 5 | 188 | 3 | 34437845 | ||
| Pubmed | Paired immunoglobulin-like receptor B is an entry receptor for mammalian orthoreovirus. | 1.54e-06 | 5 | 188 | 3 | 37147336 | |
| Pubmed | Tumor-derived ILT4 induces T cell senescence and suppresses tumor immunity. | 1.54e-06 | 5 | 188 | 3 | 33653799 | |
| Pubmed | Structure and flexibility of the extracellular region of the PirB receptor. | 1.54e-06 | 5 | 188 | 3 | 30674550 | |
| Pubmed | Inhibitory receptor paired Ig-like receptor B is exploited by Staphylococcus aureus for virulence. | 1.54e-06 | 5 | 188 | 3 | 23152562 | |
| Pubmed | Eph receptors are involved in the activity-dependent synaptic wiring in the mouse cerebellar cortex. | 1.54e-06 | 5 | 188 | 3 | 21559471 | |
| Pubmed | Paternal monoallelic expression of the paired immunoglobulin-like receptors PIR-A and PIR-B. | 1.54e-06 | 5 | 188 | 3 | 10359805 | |
| Pubmed | 1.54e-06 | 5 | 188 | 3 | 10586026 | ||
| Pubmed | Embryonic stem cells express multiple Eph-subfamily receptor tyrosine kinases. | 1.54e-06 | 5 | 188 | 3 | 8552593 | |
| Pubmed | 1.54e-06 | 5 | 188 | 3 | 9550322 | ||
| Pubmed | Expression of PirB protein in intact and injured optic nerve and retina of mice. | 1.54e-06 | 5 | 188 | 3 | 22102155 | |
| Pubmed | 1.54e-06 | 5 | 188 | 3 | 23258232 | ||
| Pubmed | 1.93e-06 | 205 | 188 | 9 | 20436479 | ||
| Pubmed | 2.38e-06 | 18 | 188 | 4 | 16854408 | ||
| Pubmed | 3.05e-06 | 162 | 188 | 8 | 25826454 | ||
| Pubmed | HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor. | 3.07e-06 | 6 | 188 | 3 | 12207326 | |
| Pubmed | 3.07e-06 | 6 | 188 | 3 | 9824165 | ||
| Pubmed | 3.07e-06 | 6 | 188 | 3 | 38383888 | ||
| Pubmed | 3.07e-06 | 6 | 188 | 3 | 39095838 | ||
| Pubmed | Area specificity and topography of thalamocortical projections are controlled by ephrin/Eph genes. | 3.07e-06 | 6 | 188 | 3 | 12895420 | |
| Pubmed | PIR-B-deficient mice are susceptible to Salmonella infection. | 3.07e-06 | 6 | 188 | 3 | 18768880 | |
| Pubmed | LILRB2/PirB mediates macrophage recruitment in fibrogenesis of nonalcoholic steatohepatitis. | 3.07e-06 | 6 | 188 | 3 | 37481670 | |
| Pubmed | 3.07e-06 | 6 | 188 | 3 | 31727773 | ||
| Pubmed | 3.07e-06 | 6 | 188 | 3 | 30787106 | ||
| Pubmed | 3.07e-06 | 6 | 188 | 3 | 21636572 | ||
| Pubmed | 3.07e-06 | 6 | 188 | 3 | 24040397 | ||
| Pubmed | 3.07e-06 | 6 | 188 | 3 | 30068593 | ||
| Pubmed | 3.07e-06 | 6 | 188 | 3 | 15996548 | ||
| Pubmed | 3.07e-06 | 6 | 188 | 3 | 28664612 | ||
| Pubmed | Cell-Autonomous Regulation of Dendritic Spine Density by PirB. | 3.07e-06 | 6 | 188 | 3 | 27752542 | |
| Pubmed | PirB is a functional receptor for myelin inhibitors of axonal regeneration. | 3.07e-06 | 6 | 188 | 3 | 18988857 | |
| Pubmed | 3.07e-06 | 6 | 188 | 3 | 27402837 | ||
| Pubmed | 3.07e-06 | 6 | 188 | 3 | 28594961 | ||
| Pubmed | The p75 receptor mediates axon growth inhibition through an association with PIR-B. | 3.07e-06 | 6 | 188 | 3 | 21881600 | |
| Pubmed | Impaired dendritic cell maturation and increased T(H)2 responses in PIR-B(-/-) mice. | 3.07e-06 | 6 | 188 | 3 | 12021780 | |
| Pubmed | 3.07e-06 | 6 | 188 | 3 | 15146181 | ||
| Pubmed | 3.07e-06 | 6 | 188 | 3 | 29482582 | ||
| Pubmed | 3.07e-06 | 6 | 188 | 3 | 25320232 | ||
| Interaction | ZNF783 interactions | 1.98e-06 | 11 | 181 | 4 | int:ZNF783 | |
| Interaction | EFNA5 interactions | 2.56e-06 | 68 | 181 | 7 | int:EFNA5 | |
| Interaction | FTSJ1 interactions | 4.98e-06 | 75 | 181 | 7 | int:FTSJ1 | |
| Interaction | FAM171A2 interactions | 7.78e-06 | 112 | 181 | 8 | int:FAM171A2 | |
| Interaction | ZNF767P interactions | 1.05e-05 | 16 | 181 | 4 | int:ZNF767P | |
| Interaction | NTPCR interactions | 3.21e-05 | 136 | 181 | 8 | int:NTPCR | |
| Interaction | ZNF398 interactions | 4.04e-05 | 43 | 181 | 5 | int:ZNF398 | |
| Interaction | TOP3B interactions | ENGASE MGAT4B ZNF585A ZNF48 SZT2 MYO9B SPEG TMEM158 RNPEPL1 KAT6A OBSCN ANKLE1 KAT2A LARS2 ADCY9 C6orf132 ARHGEF40 LLGL2 SYNE3 ATP6AP2 CD2BP2 SBF2 HPS6 CACNA1H ZNF324B SSBP4 MMP14 FOXK1 SEC23B | 4.99e-05 | 1470 | 181 | 29 | int:TOP3B |
| Cytoband | 7q36.1 | 6.40e-07 | 74 | 188 | 6 | 7q36.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q36 | 5.28e-05 | 159 | 188 | 6 | chr7q36 | |
| Cytoband | 17q21 | 1.34e-04 | 63 | 188 | 4 | 17q21 | |
| GeneFamily | Fibronectin type III domain containing | CNTN4 SDK2 OBSCN IGDCC3 NCAM2 FNDC3A CSF3R EPHA2 ROBO1 ROBO3 SDK1 CNTN2 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 4.47e-15 | 160 | 137 | 17 | 555 |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 4.84e-10 | 14 | 137 | 6 | 1095 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | CNTN4 SDK2 SPEG OBSCN IGDCC3 NCAM2 HMCN1 ROBO1 FGFR4 ROBO3 SDK1 CNTN2 | 3.51e-09 | 161 | 137 | 12 | 593 |
| GeneFamily | CD molecules|Inhibitory leukocyte immunoglobulin like receptors | 4.21e-06 | 5 | 137 | 3 | 1182 | |
| GeneFamily | Sterile alpha motif domain containing | 4.68e-06 | 88 | 137 | 7 | 760 | |
| GeneFamily | Immunoglobulin like domain containing | 1.65e-05 | 193 | 137 | 9 | 594 | |
| GeneFamily | Myosins, class IX | 5.70e-05 | 2 | 137 | 2 | 1103 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.68e-04 | 17 | 137 | 3 | 486 | |
| GeneFamily | Regulating synaptic membrane exocytosis family|PDZ domain containing | 3.39e-04 | 4 | 137 | 2 | 833 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 4.41e-04 | 20 | 137 | 3 | 736 | |
| GeneFamily | WD repeat domain containing|Coronins | 1.17e-03 | 7 | 137 | 2 | 495 | |
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 1.17e-03 | 7 | 137 | 2 | 1201 | |
| GeneFamily | E2F transcription factors | 1.55e-03 | 8 | 137 | 2 | 982 | |
| GeneFamily | Paraneoplastic Ma antigens | 3.00e-03 | 11 | 137 | 2 | 671 | |
| GeneFamily | C2 domain containing|Calpains | 5.61e-03 | 15 | 137 | 2 | 975 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C11_PANETH_LIKE_CELL | LILRB2 RUBCNL KLHDC7B LILRB1 ADCY9 CSF3R FES MMP9 CORO7 FYB1 SLC23A2 LILRB5 | 3.80e-06 | 324 | 186 | 12 | M39160 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DNAH10 KIF26B OBSCN NCAM2 CAPN8 HMCN1 ROBO1 SDK1 CNTN2 EPHA5 | 6.18e-09 | 184 | 187 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DNAH10 KIF26B OBSCN NCAM2 CAPN8 HMCN1 ROBO1 SDK1 CNTN2 EPHA5 | 6.18e-09 | 184 | 187 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DNAH10 KIF26B OBSCN NCAM2 CAPN8 HMCN1 ROBO1 SDK1 CNTN2 EPHA5 | 6.18e-09 | 184 | 187 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | facs-MAT-Fat-24m-Myeloid|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.78e-07 | 168 | 187 | 8 | 6514a27a54ea0f07172b3a73270250143a7b14f0 | |
| ToppCell | facs-MAT-Fat-24m-Myeloid-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.78e-07 | 168 | 187 | 8 | 0b6bb335e93476b13955543eeb487243b0067369 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.04e-07 | 169 | 187 | 8 | bf0a97f53d6e3f9ffeaeae0402b010c49a6cccb7 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.04e-07 | 169 | 187 | 8 | 05b138511039f1255a5f647040b1b9bdf222bd52 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-06 | 182 | 187 | 8 | c3eafdc11858566aa7692b2f5dbe72ac01fb769a | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.35e-06 | 188 | 187 | 8 | cb091912f9b627a78a8793a37df7f1de839f887f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-06 | 189 | 187 | 8 | e059be2965cca70ff5576df055d0af1775b76e00 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.52e-06 | 191 | 187 | 8 | 5d6ef70cc15ec5e983a953e547e40f9c06e355fb | |
| ToppCell | wk_20-22-Hematologic-Myeloid-DC3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.64e-06 | 193 | 187 | 8 | 12d1e7ed0bcd1259d6dc8ae962aad69586e5d26b | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-06 | 194 | 187 | 8 | dfe0ece81922bfd7c6673726d3ea2365cbdb5513 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-06 | 195 | 187 | 8 | 10ce1b6961f10372d1f65388cbf3626a5fcd6840 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-iMON-iMON|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.84e-06 | 196 | 187 | 8 | 8608be3c3e7fd776c5f2fae207cd0b801e138349 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-iMON|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.84e-06 | 196 | 187 | 8 | 5842d6fa0c066815d7d8c7e59b192bfc72960707 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-06 | 198 | 187 | 8 | 96883ad8e189a46ed5b7eaafc0543e53682d26ed | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-06 | 198 | 187 | 8 | 623f9d64c9e800d2d7f623392bf2f22b563f0249 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.14e-06 | 200 | 187 | 8 | 700960201ae0df2c79e2907f5a0f95d73f8034fe | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A--L4-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.14e-06 | 200 | 187 | 8 | cb1f4b0d66da5b0466ff17b29e7034d451d93e4f | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.14e-06 | 200 | 187 | 8 | 6a44439e4a7ce3627271375b04cfcfb9467218f4 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.14e-06 | 200 | 187 | 8 | 8d51b4f7b7002ee51401ebe5eaca1e8f04bfadd5 | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.60e-06 | 144 | 187 | 7 | 8bd042f12186f36bc5aabf6a0232270a448f4b58 | |
| ToppCell | Control-Endothelial-Epi-like-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.61e-06 | 157 | 187 | 7 | 2c369660c752c0fb3bd798a561d3359e2f9aa983 | |
| ToppCell | Control-Endothelial-Epi-like|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.61e-06 | 157 | 187 | 7 | 4d02c50d5d1b892ea241e98724386d8a5a156a46 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Myeloid|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-06 | 161 | 187 | 7 | 3db97af49520dc8cbafb4454d8afd9d588160e89 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Myeloid-macrophage|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-06 | 161 | 187 | 7 | f1d258c81bcf0f3c52bd20aa58faa9a5fd888168 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Myeloid-macrophage|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-06 | 161 | 187 | 7 | 787f91f906756ef570c0d02936c3cdfafb3f7454 | |
| ToppCell | droplet-Kidney-nan-24m-Myeloid-CD45____macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.15e-06 | 164 | 187 | 7 | d57faa4fce1f1e9a92aaf5cb920af99323252e4b | |
| ToppCell | droplet-Kidney-nan-24m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.15e-06 | 164 | 187 | 7 | d0b6c29e61d15f4dbe4c1f6e5ed3e10f41f820ab | |
| ToppCell | droplet-Kidney-nan-24m-Myeloid|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.15e-06 | 164 | 187 | 7 | 718cc64b7ef7d03d095be4b2b54c449154da568c | |
| ToppCell | facs-MAT-Fat-18m-Myeloid|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.65e-06 | 166 | 187 | 7 | 9116be2805c34881debb999d8417e43832fcf2f2 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.65e-06 | 166 | 187 | 7 | 83d0c26ccee605df6b04bbca31661bf4ff4f22ba | |
| ToppCell | facs-MAT-Fat-18m-Myeloid-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.65e-06 | 166 | 187 | 7 | 5c2667da79935f3d4b1edbfe7a10e7dbc2fa3ad0 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-classical_monocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.92e-06 | 167 | 187 | 7 | d62d5dec30d006a9cc8f3bc5ccc578e10f105027 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.20e-06 | 168 | 187 | 7 | 3d8c431a3c8899383212fe6a7627889c40c5f3ef | |
| ToppCell | droplet-Fat-Scat-18m-Myeloid-myeloid_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.20e-06 | 168 | 187 | 7 | 94916feefd413c84bb7d3fd2d3e403036b705b69 | |
| ToppCell | droplet-Fat-Scat-18m-Myeloid|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.20e-06 | 168 | 187 | 7 | 02dfe8037e61f9d4ac5f8df3929673bc212fd2cd | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.48e-06 | 169 | 187 | 7 | 15d5758d94a14a909d1d0c8bba9ce497a33d1512 | |
| ToppCell | droplet-Spleen-nan-21m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.48e-06 | 169 | 187 | 7 | 7962165cab84af73d20b56eb70b1ed87c94025ef | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.48e-06 | 169 | 187 | 7 | c6750c45c44be68aea39e918ba97c6f875ccea34 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.78e-06 | 170 | 187 | 7 | 3e52d40b0c36ab5b627a2dad025248901af8a320 | |
| ToppCell | droplet-Heart-4Chambers-21m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.08e-06 | 171 | 187 | 7 | e852d0e8589eecf4a2e5fea039b52a67c5d58dbd | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic-Neutrophil|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.75e-06 | 176 | 187 | 7 | 676839d07450b313222622e0ffd305c732cbad6d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.75e-06 | 176 | 187 | 7 | 926ed37e636fe4dd3a18731cea15761f0c2c285a | |
| ToppCell | facs-Liver-Non-hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 177 | 187 | 7 | f73ed860685a724591d0f543a9ac4e868aff92f5 | |
| ToppCell | metastatic_Brain-B_lymphocytes-GrB-secreting_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 1.01e-05 | 177 | 187 | 7 | 43e1d0d3cf8f0c02e67d91f8dd1761df23d59e07 | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 179 | 187 | 7 | d50d29f26d5a2cd8c4cd4e1244e1bb8de072d159 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-Macrophages|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-05 | 180 | 187 | 7 | 7af90f0e7ca001bf1fe5c860ee54c4cc8eb483bf | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 182 | 187 | 7 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.26e-05 | 183 | 187 | 7 | f803dd2881ceaed6327e21a1a51bc3d3ccf4b5f8 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.26e-05 | 183 | 187 | 7 | cff3197e9ff401362501db2317c86adc6d24b595 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.26e-05 | 183 | 187 | 7 | 4bd6883daf2dbe8c1b49b776b48d41f9890d1cb4 | |
| ToppCell | COVID-19_Mild-Neu_3|World / 5 Neutrophil clusters in COVID-19 patients | 1.29e-05 | 122 | 187 | 6 | 2aa9cfadab70312882ae679e3788fc7ab996c0f3 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 184 | 187 | 7 | 1da7936a2616986efd5de601ad525f1f2355128a | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 184 | 187 | 7 | 1c857126c0ea0671f0d60b048efca288d348d653 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.35e-05 | 185 | 187 | 7 | 1ac6a32cc56d5d819649bdd99518e2ead0eead4c | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 185 | 187 | 7 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL14A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 1.40e-05 | 186 | 187 | 7 | 6259f0f2d5bc863782d09a901d6be2f387d1f074 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 1.44e-05 | 187 | 187 | 7 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.50e-05 | 188 | 187 | 7 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.50e-05 | 188 | 187 | 7 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.50e-05 | 188 | 187 | 7 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | cellseq-Immune-Hematopoietic-Granulocytic-Neutrophil|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.55e-05 | 189 | 187 | 7 | fedab592be1d6520325b8c1b659b0a4dc3f4fe4d | |
| ToppCell | droplet-Spleen-nan-24m-Lymphocytic-plasma_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 190 | 187 | 7 | 992539c380576bf810c00a5f926cf1ee7d57dcf5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-05 | 190 | 187 | 7 | 788ff9d8888d2dd25b7e1d7e0e5d57751ce86f19 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-S100A12-hi_cla._mono.|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.60e-05 | 190 | 187 | 7 | b8c131020d20005cd9f23d26312196f62c958074 | |
| ToppCell | 10x5'-Lung-Myeloid_Monocytic-Classical_monocytes|Lung / Manually curated celltypes from each tissue | 1.60e-05 | 190 | 187 | 7 | a2574f0876ebae3a1d2a39a79cc6cadac8ee1688 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-05 | 191 | 187 | 7 | baa70781633a3fe5bf987f9d8dff3884f5167e7f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-05 | 191 | 187 | 7 | c72e62cf5b45c04ee5e7719db31f917c4f76b1e4 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage2_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.66e-05 | 191 | 187 | 7 | 09dfad8e1fcaaf94775134796b99e4e3fbb9bf40 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-05 | 193 | 187 | 7 | f597fefc54327a1ad136e2f66b6e81cc5c761eb7 | |
| ToppCell | 10x5'-Lung-Myeloid_Monocytic|Lung / Manually curated celltypes from each tissue | 1.77e-05 | 193 | 187 | 7 | ebe6be10ef5de9e1da988e263106698d3db42fce | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_macrophage|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.83e-05 | 194 | 187 | 7 | ef30baa19b7aa97b61dea916fc2e0f5cf49848d6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.83e-05 | 194 | 187 | 7 | 83863da11dfbe59b2d0a2c08db40b537c150588c | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.83e-05 | 194 | 187 | 7 | 44a90be1d2b2ae08f8c523bee65dd1e536ec0f95 | |
| ToppCell | 18-Airway-Immune-Hematopoietic,_Macrophage|Airway / Age, Tissue, Lineage and Cell class | 1.83e-05 | 194 | 187 | 7 | 9671fed8cd45ea8c7a411239aa5012c2a1edf264 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 194 | 187 | 7 | 0866ab6792cee274a71991d5c37a37f574ff446e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 194 | 187 | 7 | badefcec2af86cbcd97305f4843e84db0f3ebc66 | |
| ToppCell | 21-Trachea-Immune-Hematopoietic,_Macrophage|Trachea / Age, Tissue, Lineage and Cell class | 1.83e-05 | 194 | 187 | 7 | 3c4ac5f91b10802990b84db3406f5e71f8ee8b74 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_monocytic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.89e-05 | 195 | 187 | 7 | 6c354c38ee2965d37152ffdc86ba929ba2049c6a | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.89e-05 | 195 | 187 | 7 | 028622b234551b185977fbee10c06851a45456a5 | |
| ToppCell | COVID-19-Myeloid-Monocytes|COVID-19 / group, cell type (main and fine annotations) | 1.96e-05 | 196 | 187 | 7 | 04d710267658ea5601ae2cfb4ed5acb8a29bd8a1 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.96e-05 | 196 | 187 | 7 | f667430a61bc962e4d033818a05348bf40762041 | |
| ToppCell | moderate-Myeloid|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.96e-05 | 196 | 187 | 7 | 76a4c615ea7594e99c1a938d6900a1b262cc09f5 | |
| ToppCell | NS-moderate-d_16-33-Myeloid|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.96e-05 | 196 | 187 | 7 | dc8483625f1188771eb98bd94757b25163b2fc2f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-05 | 196 | 187 | 7 | 4370473693d2dd4a8c451a4c477eb79baa33ae12 | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.02e-05 | 197 | 187 | 7 | 48a8169a4d33c6a68d66bcd936861c75cb4b60ef | |
| ToppCell | NS-control-d_0-4-Myeloid-Non-resident_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.02e-05 | 197 | 187 | 7 | 496a1115071a1be6928786192de49f3adf197dfb | |
| ToppCell | wk_15-18-Hematologic|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.02e-05 | 197 | 187 | 7 | ecc2f84c1f7442cad668a534e59eccc637dfbf44 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.02e-05 | 197 | 187 | 7 | d568354aff89ac84dd06360f19100ef578a041ed | |
| ToppCell | distal-Hematologic-Classical_Monocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.02e-05 | 197 | 187 | 7 | 9f4b0857012cd503e668bac115010216a946f73c | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.02e-05 | 197 | 187 | 7 | 09a2c0c0f9c2442743414236c2d5c1f27be66e4c | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type | 2.02e-05 | 197 | 187 | 7 | a0f8a992282a6d64890f5574c7c9741fcb38dadd | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.09e-05 | 198 | 187 | 7 | ea34096bee852a7e996f097fa279381afa8f86ff | |
| ToppCell | cellseq2-Immune-Immune_Myeloid-iMON-iMON|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.09e-05 | 198 | 187 | 7 | a6aa113f0af4d25c032f440c3134fe4d88ca5055 | |
| ToppCell | distal-Hematologic-Interstitial_Macrophage|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.09e-05 | 198 | 187 | 7 | a35b43d38e18c6f8f0cd9015b8e23f71c729f023 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.09e-05 | 198 | 187 | 7 | d42fce8e547dc97f3cf144ab65483a1b11ace267 | |
| ToppCell | COVID-19-kidney-Macrophages|kidney / Disease (COVID-19 only), tissue and cell type | 2.09e-05 | 198 | 187 | 7 | 161324541fe5da5cbb58142ea94fefd39b7dfb04 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.09e-05 | 198 | 187 | 7 | 23314bed02edadccdc5da4fa153142a25e4a440e | |
| Computational | Genes in the cancer module 85. | 8.49e-06 | 51 | 103 | 6 | MODULE_85 | |
| Computational | Genes in the cancer module 199. | 1.63e-05 | 57 | 103 | 6 | MODULE_199 | |
| Computational | RTK signaling. | 7.35e-05 | 46 | 103 | 5 | MODULE_259 | |
| Computational | Genes in the cancer module 200. | 1.18e-04 | 27 | 103 | 4 | MODULE_200 | |
| Computational | Porins / transporters. | 1.86e-04 | 211 | 103 | 9 | MODULE_63 | |
| Computational | Genes in the cancer module 80. | 2.33e-04 | 32 | 103 | 4 | MODULE_80 | |
| Computational | Genes in the cancer module 51. | 3.70e-04 | 36 | 103 | 4 | MODULE_51 | |
| Drug | DFC-28 | 6.50e-08 | 14 | 186 | 5 | CID005743054 | |
| Drug | celecoxib; Down 200; 10uM; MCF7; HT_HG-U133A_EA | IFT140 MYO9B MBD1 ARMC9 ADCY9 LLGL2 SLC12A9 CEP250 HPS6 SLC23A2 EPHA3 | 7.05e-07 | 197 | 186 | 11 | 922_DN |
| Drug | Carbachol [51-83-2]; Down 200; 21.8uM; PC3; HT_HG-U133A | IL11RA SH3TC2 IFT140 ZNF862 SPEG RNPEPL1 APBB2 RTN2 SYDE1 ZNF324B FYB1 | 7.41e-07 | 198 | 186 | 11 | 6742_DN |
| Drug | ponatinib | 1.38e-06 | 68 | 186 | 7 | ctd:C545373 | |
| Drug | VX-745 | 1.60e-06 | 25 | 186 | 5 | CID003038525 | |
| Drug | Chenodiol [474-25-9]; Down 200; 10.2uM; PC3; HT_HG-U133A | IL11RA SH3TC2 SZT2 SPEG ZNF212 CD2BP2 MMP14 SLC23A2 EPHA4 EPHA5 | 5.59e-06 | 198 | 186 | 10 | 7310_DN |
| Drug | Hymecromone [90-33-5]; Down 200; 22.8uM; MCF7; HT_HG-U133A | RNPEPL1 APBB2 FNDC3A ADCY9 TGFBR3 CAPN5 TAF1 NOS1 SLC23A2 EPHA3 | 5.59e-06 | 198 | 186 | 10 | 5684_DN |
| Drug | Metrizamide [31112-62-6]; Down 200; 5uM; PC3; HT_HG-U133A | SH3TC2 PHF20 SZT2 LARS2 ZNF783 TAF1 ZNF324B MMP9 MMP14 SLC23A2 | 6.11e-06 | 200 | 186 | 10 | 4075_DN |
| Drug | Zardaverine [101975-10-4]; Up 200; 15uM; HL60; HT_HG-U133A | 1.50e-05 | 176 | 186 | 9 | 2926_UP | |
| Drug | BIRB796 | 1.66e-05 | 66 | 186 | 6 | CID000156422 | |
| Drug | Naftopidil dihydrochloride [57149-08-3]; Up 200; 8.6uM; HL60; HT_HG-U133A | 2.76e-05 | 190 | 186 | 9 | 2911_UP | |
| Drug | Pentamidine isethionate [140-64-7]; Down 200; 6.8uM; HL60; HT_HG-U133A | 3.52e-05 | 196 | 186 | 9 | 2473_DN | |
| Drug | Maprotiline hydrochloride [10347-81-6]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 3.52e-05 | 196 | 186 | 9 | 5022_DN | |
| Drug | Trimethoprim [738-70-5]; Down 200; 13.8uM; PC3; HT_HG-U133A | 3.52e-05 | 196 | 186 | 9 | 7377_DN | |
| Drug | Solasodine [126-17-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 3.52e-05 | 196 | 186 | 9 | 3830_DN | |
| Drug | Yohimbine hydrochloride [65-19-0]; Down 200; 10.2uM; MCF7; HT_HG-U133A | MYO9B ZNF862 RNPEPL1 TRIOBP SLC12A9 PLEKHG3 C8orf44 FGFR4 NOS1 | 3.52e-05 | 196 | 186 | 9 | 2755_DN |
| Drug | Cefadroxil [50370-12-2]; Up 200; 11uM; MCF7; HT_HG-U133A | 3.52e-05 | 196 | 186 | 9 | 3259_UP | |
| Drug | Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Up 200; 17.8uM; MCF7; HT_HG-U133A | 3.66e-05 | 197 | 186 | 9 | 2654_UP | |
| Drug | Iopamidol [60166-93-0]; Down 200; 5.2uM; PC3; HT_HG-U133A | SH3TC2 EGLN2 LILRB2 SPEG RNPEPL1 TTLL5 SYDE1 MICALL2 SLC12A9 | 3.96e-05 | 199 | 186 | 9 | 5832_DN |
| Drug | N6,2'-O-Dibutyryladenosine 3',5'-cyclic monophosphate sodium salt; Down 200; 20uM; MCF7; HG-U133A | 3.96e-05 | 199 | 186 | 9 | 591_DN | |
| Drug | Perphenazine [58-39-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 3.96e-05 | 199 | 186 | 9 | 5698_DN | |
| Drug | Dibucaine [85-79-0]; Up 200; 11.6uM; HL60; HG-U133A | 4.12e-05 | 200 | 186 | 9 | 1969_UP | |
| Drug | 6-deoxy-6-bromoascorbic acid | 6.64e-05 | 2 | 186 | 2 | ctd:C068572 | |
| Disease | retinal drusen | 1.66e-05 | 51 | 184 | 5 | EFO_1001155 | |
| Disease | threonate measurement | 2.77e-05 | 10 | 184 | 3 | EFO_0021032 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 2 measurement | 3.79e-05 | 11 | 184 | 3 | EFO_0008209 | |
| Disease | schizophrenia (implicated_via_orthology) | 6.77e-05 | 68 | 184 | 5 | DOID:5419 (implicated_via_orthology) | |
| Disease | ascorbic acid 3-sulfate measurement | 8.25e-05 | 14 | 184 | 3 | EFO_0800173 | |
| Disease | intracranial aneurysm (is_marker_for) | 8.25e-05 | 14 | 184 | 3 | DOID:10941 (is_marker_for) | |
| Disease | glycerate measurement | 1.03e-04 | 15 | 184 | 3 | EFO_0021029 | |
| Disease | X-24431 measurement | 1.16e-04 | 3 | 184 | 2 | EFO_0800882 | |
| Disease | Gastric Adenocarcinoma | 1.79e-04 | 45 | 184 | 4 | C0278701 | |
| Disease | tartronate (hydroxymalonate) measurement | 2.30e-04 | 4 | 184 | 2 | EFO_0800944 | |
| Disease | primary hyperaldosteronism (is_implicated_in) | 3.82e-04 | 5 | 184 | 2 | DOID:446 (is_implicated_in) | |
| Disease | extraversion measurement | 5.71e-04 | 6 | 184 | 2 | EFO_0007913 | |
| Disease | Idiopathic generalized epilepsy | 5.71e-04 | 6 | 184 | 2 | cv:C0270850 | |
| Disease | smoking status measurement, Cannabis use, schizophrenia | 7.74e-04 | 29 | 184 | 3 | EFO_0006527, EFO_0007585, MONDO_0005090 | |
| Disease | myoclonic-atonic epilepsy (implicated_via_orthology) | 7.96e-04 | 7 | 184 | 2 | DOID:0060475 (implicated_via_orthology) | |
| Disease | Morphine Abuse | 7.96e-04 | 7 | 184 | 2 | C0600272 | |
| Disease | Morphine Dependence | 7.96e-04 | 7 | 184 | 2 | C0026552 | |
| Disease | right ventricular ejection fraction measurement | 8.56e-04 | 30 | 184 | 3 | EFO_0021816 | |
| Disease | Squamous cell carcinoma of lung | 1.04e-03 | 32 | 184 | 3 | C0149782 | |
| Disease | cognitive disorder (biomarker_via_orthology) | 1.06e-03 | 8 | 184 | 2 | DOID:1561 (biomarker_via_orthology) | |
| Disease | BMI-adjusted waist circumference, physical activity measurement | 1.07e-03 | 123 | 184 | 5 | EFO_0007789, EFO_0008002 | |
| Disease | right ventricular systolic volume measurement | 1.35e-03 | 35 | 184 | 3 | EFO_0021815 | |
| Disease | brain ischemia (implicated_via_orthology) | 1.35e-03 | 35 | 184 | 3 | DOID:2316 (implicated_via_orthology) | |
| Disease | uric acid measurement | CNTN4 SLC52A1 MYO9A SLC5A9 ADCY9 DDX1 DAZAP1 MICALL2 SBF2 RNASEH2C FOXK1 | 1.64e-03 | 610 | 184 | 11 | EFO_0004761 |
| Disease | abdominal aortic aneurysm (is_marker_for) | 1.68e-03 | 10 | 184 | 2 | DOID:7693 (is_marker_for) | |
| Disease | Aortic Aneurysm, Abdominal | 1.68e-03 | 10 | 184 | 2 | C0162871 | |
| Disease | polymyositis (is_marker_for) | 2.05e-03 | 11 | 184 | 2 | DOID:0080745 (is_marker_for) | |
| Disease | Pancreatic Ductal Adenocarcinoma | 2.05e-03 | 11 | 184 | 2 | C1335302 | |
| Disease | obstructive sleep apnea (is_implicated_in) | 2.05e-03 | 11 | 184 | 2 | DOID:0050848 (is_implicated_in) | |
| Disease | Charcot-Marie-Tooth disease | 2.29e-03 | 42 | 184 | 3 | cv:C0007959 | |
| Disease | obesity (implicated_via_orthology) | 2.37e-03 | 215 | 184 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | prediabetes syndrome (biomarker_via_orthology) | 2.45e-03 | 12 | 184 | 2 | DOID:11716 (biomarker_via_orthology) | |
| Disease | kynurenic acid measurement | 2.88e-03 | 13 | 184 | 2 | EFO_0010506 | |
| Disease | intracranial aneurysm (biomarker_via_orthology) | 2.88e-03 | 13 | 184 | 2 | DOID:10941 (biomarker_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease type 4 | 2.88e-03 | 13 | 184 | 2 | cv:C4082197 | |
| Disease | Diabetic Neuralgia | 3.35e-03 | 14 | 184 | 2 | C0751074 | |
| Disease | thoracic aortic aneurysm (is_marker_for) | 3.35e-03 | 14 | 184 | 2 | DOID:14004 (is_marker_for) | |
| Disease | Diabetic Neuropathies | 3.35e-03 | 14 | 184 | 2 | C0011882 | |
| Disease | Asymmetric Diabetic Proximal Motor Neuropathy | 3.35e-03 | 14 | 184 | 2 | C0271674 | |
| Disease | Symmetric Diabetic Proximal Motor Neuropathy | 3.35e-03 | 14 | 184 | 2 | C0271673 | |
| Disease | Diabetic Mononeuropathy | 3.35e-03 | 14 | 184 | 2 | C0271678 | |
| Disease | Diabetic Autonomic Neuropathy | 3.35e-03 | 14 | 184 | 2 | C0271686 | |
| Disease | Diabetic Amyotrophy | 3.35e-03 | 14 | 184 | 2 | C0271685 | |
| Disease | Diabetic Polyneuropathies | 3.35e-03 | 14 | 184 | 2 | C0271680 | |
| Disease | Diabetic Asymmetric Polyneuropathy | 3.35e-03 | 14 | 184 | 2 | C0393835 | |
| Disease | schizophrenia, anorexia nervosa | 3.36e-03 | 48 | 184 | 3 | MONDO_0005090, MONDO_0005351 | |
| Disease | brain connectivity measurement | 3.76e-03 | 400 | 184 | 8 | EFO_0005210 | |
| Disease | cognitive inhibition measurement | 3.77e-03 | 50 | 184 | 3 | EFO_0007969 | |
| Disease | Disease Exacerbation | 3.84e-03 | 165 | 184 | 5 | C0235874 | |
| Disease | relapsing-remitting multiple sclerosis (is_marker_for) | 3.85e-03 | 15 | 184 | 2 | DOID:2378 (is_marker_for) | |
| Disease | chenodeoxycholate measurement | 3.85e-03 | 15 | 184 | 2 | EFO_0010471 | |
| Disease | disease recurrence, colon carcinoma | 3.99e-03 | 51 | 184 | 3 | EFO_0004952, EFO_1001950 | |
| Disease | urate measurement | SLC52A1 MYO9A SLC5A9 DDX1 MICALL2 SBF2 RNASEH2C UHRF1 OTUD3 FGFR4 FOXK1 CNTN2 EPHA4 | 4.20e-03 | 895 | 184 | 13 | EFO_0004531 |
| Disease | age at menarche | IQANK1 CPA5 WWP2 ZC3HC1 FNDC3A LEPR SEMA6D EIF4G3 SPINDOC EPHA5 | 4.28e-03 | 594 | 184 | 10 | EFO_0004703 |
| Disease | vitamin C measurement | 4.38e-03 | 16 | 184 | 2 | EFO_0600003 | |
| Disease | congestive heart failure (biomarker_via_orthology) | 4.58e-03 | 107 | 184 | 4 | DOID:6000 (biomarker_via_orthology) | |
| Disease | mitochondrial DNA measurement | 4.66e-03 | 328 | 184 | 7 | EFO_0006312 | |
| Disease | Metastatic melanoma | 4.69e-03 | 54 | 184 | 3 | C0278883 | |
| Disease | dermatomyositis (is_marker_for) | 4.95e-03 | 17 | 184 | 2 | DOID:10223 (is_marker_for) | |
| Disease | aortic measurement | 5.04e-03 | 251 | 184 | 6 | EFO_0020865 | |
| Disease | endometrial carcinoma | 5.56e-03 | 113 | 184 | 4 | EFO_1001512 | |
| Disease | pre-eclampsia (is_marker_for) | 5.72e-03 | 58 | 184 | 3 | DOID:10591 (is_marker_for) | |
| Disease | neuroticism measurement, wellbeing measurement, depressive symptom measurement | 6.17e-03 | 19 | 184 | 2 | EFO_0007006, EFO_0007660, EFO_0007869 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PPSVRGKVWSLAVGN | 486 | O60347 | |
| PWDGRAAPLGKRTEE | 106 | Q6ZR03 | |
| VGRKPVDGTRPDNLW | 1371 | Q68DN1 | |
| RKNVPPGESRWKEQP | 336 | Q8N715 | |
| GPISPGVIEDWKRIT | 346 | Q6P461 | |
| TAPEKRGWVINPLGE | 971 | P04920 | |
| KAQRLREGEPGWVHP | 141 | O94766 | |
| IRIVPLAWNPRGKIG | 146 | P78357 | |
| TPEWLQGINKDRPTG | 146 | Q8TER5 | |
| DLPPGWKRVSDIAGT | 291 | Q92870 | |
| PDPARRWREGVVKSS | 436 | Q8NAG6 | |
| PALWEAKAGRSPEVR | 46 | Q96CB5 | |
| RKLARAESAPRPWDG | 481 | Q400G9 | |
| GPVRAWKNPERGSKS | 166 | A8MYA2 | |
| RWDPSKVNILVPGAG | 196 | Q8N4J0 | |
| DTAWPGAPGVKQARI | 96 | Q6RUI8 | |
| KEKRPPQTLSRGWGD | 26 | Q8TD06 | |
| RGGKIPIRWTAPEAI | 836 | P54756 | |
| GNPTPTIRWLKDGQA | 176 | P22455 | |
| GNPVPTIIWRRADGK | 251 | Q8IWV2 | |
| VREAKAIPRPDGIEW | 411 | Q6PIY7 | |
| LRRPWTEAGAVPSRK | 111 | P20800 | |
| GPAVRWKRPKGICED | 46 | O15484 | |
| GHPEKLIRLRNPWGE | 276 | A6NHC0 | |
| QPERTRPKEGWQKGP | 91 | Q96EP5 | |
| RPKEGWQKGPRSDNS | 96 | Q96EP5 | |
| GIEWNLSPVGRVTPK | 61 | P24311 | |
| KNIKVWEGIPESPRG | 451 | P50281 | |
| FKSRIRGTEDWAPPR | 396 | Q9H714 | |
| ESVPGIRETGWKPLG | 706 | Q92830 | |
| PDELPEGAQLRRVGW | 351 | Q8N6L0 | |
| AWKGPREPPQDARAE | 311 | Q86V59 | |
| SLGGKIPVRWTAPEA | 781 | P54762 | |
| WTLPGTRPERLIKGE | 301 | Q5TGI0 | |
| RGSRPQGPFLIADKW | 546 | P14780 | |
| QRPAWDTEPGRKSGL | 931 | Q6ZVH7 | |
| PVSWFRDGEPKLLQG | 56 | Q14626 | |
| VRQAPGKGLEWVGRT | 56 | A0A0B4J1Y9 | |
| PGKREPQGISWESPL | 336 | Q04759 | |
| EGTPPVRITWRKNGV | 66 | Q8IVU1 | |
| AQGEDEWPPLRKVGS | 481 | Q6P1M3 | |
| NNIGVKPRSGWAIDP | 276 | Q16706 | |
| GRLTEDPRLKPWNGS | 91 | Q9UQ53 | |
| PGGWQLSRERKQPTF | 51 | Q86WG5 | |
| PGAIVSPWRLKSGDA | 91 | Q68D85 | |
| SAIIAKPGEWLPRGR | 711 | Q7Z3E5 | |
| RKPPNSTGVRWVDGP | 1961 | Q2KJY2 | |
| GLKPQKVDFWRGPAR | 61 | Q8WXQ8 | |
| TRGGKIPIRWTAPEA | 781 | P54764 | |
| GSADRTVKLWRLPGP | 96 | P57737 | |
| VPVNPKTDRLWERLG | 446 | Q92499 | |
| LDCPALGPGWKRREV | 6 | Q9UIS9 | |
| RPEPPGQEARVQSWK | 681 | Q8IY33 | |
| QDKALRQEGLRPGPW | 26 | P50542 | |
| RITDNPEGKWLGRTA | 541 | O15117 | |
| AVGPEPTDRGLQWRS | 506 | Q8N423 | |
| RLGSLRAVWKPPGER | 191 | Q96LR2 | |
| VQVRGKRLDGPGIWS | 306 | P48357 | |
| RGKPVTLWCQGPLET | 41 | O75023 | |
| RLGNKWERLPDGPQR | 621 | O15553 | |
| KPGRARQEEGTRAPW | 131 | Q75WM6 | |
| RRPLWEEESNAKGGV | 111 | Q8N5X7 | |
| AEGVPTPRITWRKDG | 3736 | Q96RW7 | |
| RKPGEGARAEALWPR | 111 | Q8TCU5 | |
| EWKSPFGLTPKGRNR | 696 | Q8TCU5 | |
| IQQGWKPPRGRFDVL | 511 | P29475 | |
| KVPGTWRDGVRVPGE | 31 | E2RYF7 | |
| PSGRVLKQCGPLWEE | 286 | Q5T2D3 | |
| TWQPSKEGDRLIGRV | 586 | Q86UR5 | |
| RAGDEVLEWNGKPLP | 651 | Q86UR5 | |
| GDKKSPWQRREERPL | 806 | A8MVW0 | |
| VAPVEWRKGPENLRD | 3476 | Q5VST9 | |
| TWQPSKDGDRLIGRI | 646 | Q9UQ26 | |
| PKRRLSEGVEPWRGQ | 936 | Q92794 | |
| SEGVEPWRGQLKKSP | 941 | Q92794 | |
| EWGRARGQDTPKPAG | 446 | Q8NC74 | |
| RNGNWPIPGERIPDV | 31 | O75787 | |
| EIPNKWGPRLGRDAE | 911 | Q5T0Z8 | |
| DNIDWVKIRERPPGQ | 121 | O95400 | |
| WERVRGGVPLVKEKP | 301 | Q99613 | |
| VGRSDAIGPREQWEP | 126 | Q14331 | |
| ARRLGKVPAVPVQWG | 136 | P83105 | |
| SVRIWEIPEGGLKRN | 111 | Q9UQ03 | |
| ERGRKPAFKWIGPVD | 356 | Q96AV8 | |
| ERGRKPAFKWTGPEI | 336 | A0AVK6 | |
| QGRPKAKEIQLRWGP | 671 | Q9Y2H6 | |
| GAKVELRWTPPQDSG | 341 | P29317 | |
| GGKIPIRWTAPEAIS | 776 | P29317 | |
| RQPEATGWRRGIPAK | 16 | Q8WZB0 | |
| TGGKIPIRWTAPEAI | 796 | P29322 | |
| RLEATGGPIPQRWEN | 76 | Q9BV73 | |
| WGQELSPEGRRVALK | 101 | Q6P9A2 | |
| VPRSQEEPGKGSFWR | 366 | P85037 | |
| PWKEPVKAEERGRFG | 1311 | O60503 | |
| AGKPRPTVRWLRNGE | 351 | Q02246 | |
| TRGGKIPIRWTSPEA | 781 | P29320 | |
| KPQRGEASWALVGPL | 271 | Q99062 | |
| WKPVPLEEDSGRIQG | 356 | Q99062 | |
| PSVPRRGAATWGQEK | 211 | P0C7T7 | |
| PGWRQGTRITFEKEG | 186 | P59910 | |
| GWGVVEGPRKPSSRA | 191 | Q96G42 | |
| GRWKKINTEGDVPPS | 76 | Q9Y2U9 | |
| PNRILPDSVDWREKG | 111 | P25774 | |
| PEWKRAEANPRDLGA | 6 | Q86TM3 | |
| PGVPHIREWDRGKEF | 356 | Q6PII3 | |
| PKEGFRVPQAEWGRA | 721 | Q8NFI3 | |
| GARPEAPKRKWAEDG | 111 | Q96KS0 | |
| SRKPGPGRITWDELA | 31 | Q9NRG7 | |
| SKKGPEEGRWRPFII | 271 | Q13574 | |
| RSQAPPDVWKKVLGG | 536 | Q86YV9 | |
| WGPEAEPALGARRKK | 2171 | O95180 | |
| PQGKGPLAEIEFWRE | 271 | Q8IVF4 | |
| PLEARDWRQSPGEVG | 166 | Q6NYC8 | |
| RLSAKTRQGWGEPLE | 1451 | Q7Z5N4 | |
| SGAPRPAITWQKGER | 426 | Q58EX2 | |
| KLRGPPESREWGNAL | 486 | Q92630 | |
| EKRRPGVQRVDEGGW | 1021 | O43432 | |
| PGAEGKDRWALQTPT | 361 | Q96RY7 | |
| DVFSPIGERLGWDPK | 681 | P55786 | |
| GIKGLWPLRSDPNRE | 406 | Q16531 | |
| TELPGGVPRDCKWER | 631 | Q86YC3 | |
| GRWKGSEKVRDIPLP | 351 | Q9UKG9 | |
| PGLGPREKVSSWLRD | 176 | Q9BZF2 | |
| KGEPRTRAEARPWVD | 31 | Q6PHW0 | |
| PRLGWPLDQDRSKGD | 881 | Q9BVI0 | |
| SGGLRQVPVKWTAPE | 716 | P07332 | |
| KRKQTWVLEPDPGQG | 41 | O14926 | |
| KQWGPLEREPVRGQC | 241 | O75298 | |
| LEPSSRRWVLGGAKP | 76 | Q6ZW31 | |
| PWRERGLPSGSKDNN | 81 | Q86SS6 | |
| GAPRLRLDVWEKGNI | 2351 | Q5T011 | |
| LKPADIGPRSRVWAE | 266 | Q9HAU8 | |
| IRWEKNITLGEPPGF | 46 | P81877 | |
| TDGLDKPGQIRWPLA | 201 | P30531 | |
| TRAEVRGGGRKPWPQ | 116 | Q9BYD3 | |
| PAGAVQGWETEERPR | 31 | Q13162 | |
| SGVPQRQKRPGPWRT | 26 | Q5SQN1 | |
| PGEPTGFQKTRRWRG | 901 | Q6ZMZ3 | |
| GGPDVIKWERRVIPG | 21 | Q15031 | |
| GWGILPPESIKAVAR | 71 | Q7Z3H4 | |
| KRRIQENPGPWGELA | 651 | Q9Y4C2 | |
| KLQEPRGVRPSDWAP | 456 | Q2M2I3 | |
| GAVGPEPTDRGLQWR | 506 | Q8NHL6 | |
| RPPLQWEKVAPERDG | 946 | A1L390 | |
| GPGKNVPSVWRSARR | 266 | Q8IZX4 | |
| GPGKNVPSVWRSARR | 246 | P21675 | |
| NLPELKTAVGRGRAW | 196 | Q96T51 | |
| AAIPREIPGKDGVWR | 76 | Q9ULN7 | |
| GIVVARLPDGKWSAP | 66 | Q96HL8 | |
| LGQEQPEAPSRSWGK | 606 | Q2M3M2 | |
| PEGFKEVRPGRAWEE | 396 | Q8TF17 | |
| GQRWKEPPGEEPVRK | 216 | Q9BUA3 | |
| RADGRWPLVIDPLGQ | 426 | A8MXQ7 | |
| EEQVGPRWSRPLLVK | 401 | Q9C0C4 | |
| QKSGGVSRDWIGVPR | 191 | Q8WUJ1 | |
| RADGIVPETWIDGPK | 161 | Q96A35 | |
| PTGRVVGIIKRNWRP | 341 | Q9Y2L1 | |
| PWSPEKRPEGDRQLQ | 1376 | Q9H2D6 | |
| LGELQRDPWPVTQGK | 246 | Q15437 | |
| WLKGSQRVPEEPGEQ | 171 | A8K4G0 | |
| EEAARIRLGGPEPWK | 36 | P51788 | |
| KNWGAVVRSPEGTPQ | 16 | Q86WB0 | |
| RNFWILRLPPGSKGE | 91 | Q75MW2 | |
| RQAPEEWSVGLGTRP | 346 | Q2L4Q9 | |
| REEGVRGLWKGTLPN | 171 | P55916 | |
| EGPKRPQWTVPLGDS | 436 | A0A0J9YY54 | |
| PLPPGWEKRQDNGRV | 406 | O00308 | |
| DDLWVQREGLGKPQP | 76 | Q96MX3 | |
| GEPIPEITWKRAVDG | 326 | O15394 | |
| AEKRLRRGPEEDGPW | 666 | Q15772 | |
| TIPGTPEERGIRKWK | 571 | Q9UGH3 | |
| PGSPEERGLIQWKAG | 516 | Q9UHI7 | |
| TLWRQLAPGKGEQVP | 66 | Q9NWF4 | |
| RREGPKWDPARLNES | 196 | Q9H147 | |
| ELQGEPGWRLNRKPI | 206 | Q8WZ71 | |
| RWEKNITLGEPPGFL | 46 | Q9BWG4 | |
| RPVEDPWRGQQGLAE | 656 | Q96MS0 | |
| ILAPAKVVSRGGNPW | 381 | Q9BXP2 | |
| TIPGPDAKVRGALTW | 136 | Q8TDP1 | |
| RGDPVPTVRWRKDDG | 286 | Q9Y6N7 | |
| GKEPWALQGERPRQS | 81 | Q6P3V2 | |
| KGLALPWDRTRGHPD | 16 | Q6Q795 | |
| ERRAAPWIKDPNGPK | 386 | O60290 | |
| RRDDDEPGPWTKEGK | 581 | Q96T88 | |
| GKEPWLADRELTRGQ | 61 | Q969W8 | |
| RNFWILRLPPGSKGE | 121 | Q9UDV6 | |
| AVRWLLQRPGDEGPD | 611 | Q9NS98 | |
| RNFWILRLPPGSKGE | 91 | Q6NUN9 | |
| TDPLSGIPKGVRWEV | 636 | Q8NFY4 | |
| TKVGEAWQDRPGAPR | 481 | O15231 | |
| TQLDNGVRIPPSGWK | 196 | Q92995 | |
| WRGRAESPGVPVAKV | 81 | Q9H1B5 | |
| PWIVKPVASSRGRGV | 176 | Q6EMB2 | |
| RVWNEEGEDGLPRPK | 411 | Q03167 | |
| NPTWALRKGAEVPQG | 131 | Q6ZTC4 | |
| WGQEKGNEVEVGRPR | 206 | Q6ZMS7 | |
| IQLERGEEPWVPSGK | 51 | Q6AW86 | |
| AWKPVKLAGPGQRET | 1701 | B2RTY4 | |
| KGLPWQGEDPRSLLQ | 751 | Q13459 | |
| DRKIIWPGGETEKPR | 376 | Q05586 |